APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-aging and Longevity Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Anti-aging and Longevity Drugs Market Outlook and Growth Opportunities 2026

29 December 2025203 pages

Choose your research edition.

Industry ResearchAnti-aging and Longevity Drugs Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-aging and Longevity Drugs Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Anti-aging and Longevity Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-aging and Longevity Drugs Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-aging and Longevity Drugs Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Anti-aging and Longevity Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Anti-aging and Longevity Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Anti-aging and Longevity Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-aging and Longevity Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Anti-aging and Longevity Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Anti-aging and Longevity Drugs market include Centrum, GNC, Herbalmax, HUM Nutrition, MegaFood, Natrol, Nature Made, Nature's Bounty and New Chapter, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Anti-aging and Longevity Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Anti-aging and Longevity Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Anti-aging and Longevity Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Anti-aging and Longevity Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Anti-aging and Longevity Drugs Segment by Company

Centrum

GNC

Herbalmax

HUM Nutrition

MegaFood

Natrol

Nature Made

Nature's Bounty

New Chapter

Pure Encapsulations

The Vitamin Shoppe

China Resources Double-Crane Pharmaceutical Co.,Ltd.

GeneHarbor (Hong Kong) Biotechnologies Limited

Xiamen Kingdomway Group Company

Shinkowa

Yaben Chemical

Guangdong Zhongsheng Pharmaceutical Co.,Ltd.

Anti-aging and Longevity Drugs Segment by Type

Resveratrol

Coenzyme Q10 and Collagen

Biotin

Vitamins

Nicotinamide Mononucleotide (NMN)

Others

Anti-aging and Longevity Drugs Segment by Application

Retail Pharmacies

Online Pharmacies

Hospitals

Clinics

Anti-aging and Longevity Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Anti-aging and Longevity Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Anti-aging and Longevity Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Anti-aging and Longevity Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Anti-aging and Longevity Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-aging and Longevity Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-aging and Longevity Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-aging and Longevity Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Anti-aging and Longevity Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Anti-aging and Longevity Drugs industry.

Chapter 3: Detailed analysis of Anti-aging and Longevity Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Anti-aging and Longevity Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Anti-aging and Longevity Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Anti-aging and Longevity Drugs Industry Trends Table 2. Anti-aging and Longevity Drugs Industry Drivers Table 3. Anti-aging and Longevity Drugs Industry Opportunities and Challenges Table 4. Anti-aging and Longevity Drugs Industry Restraints Table 5. Global Anti-aging and Longevity Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Anti-aging and Longevity Drugs Revenue Share by Company (2021-2026) Table 7. Global Anti-aging and Longevity Drugs Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Anti-aging and Longevity Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Anti-aging and Longevity Drugs Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Anti-aging and Longevity Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Anti-aging and Longevity Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Anti-aging and Longevity Drugs Company, Product Type & Application Table 13. Global Anti-aging and Longevity Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Anti-aging and Longevity Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Resveratrol Table 18. Significant Companies of Coenzyme Q10 and Collagen Table 19. Significant Companies of Biotin Table 20. Significant Companies of Vitamins Table 21. Significant Companies of Nicotinamide Mononucleotide (NMN) Table 22. Significant Companies of Others Table 23. Global Anti-aging and Longevity Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Anti-aging and Longevity Drugs Sales Volume by Type (2021-2026) & (K Units) Table 25. Global Anti-aging and Longevity Drugs Sales Volume by Type (2027-2032) & (K Units) Table 26. Global Anti-aging and Longevity Drugs Sales Volume Share by Type (2021-2026) Table 27. Global Anti-aging and Longevity Drugs Sales Volume Share by Type (2027-2032) Table 28. Global Anti-aging and Longevity Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Anti-aging and Longevity Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global Anti-aging and Longevity Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global Anti-aging and Longevity Drugs Sales Value Share by Type (2021-2026) Table 32. Global Anti-aging and Longevity Drugs Sales Value Share by Type (2027-2032) Table 33. Significant Companies of Retail Pharmacies Table 34. Significant Companies of Online Pharmacies Table 35. Significant Companies of Hospitals Table 36. Significant Companies of Clinics Table 37. Global Anti-aging and Longevity Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Anti-aging and Longevity Drugs Sales Volume by Application (2021-2026) & (K Units) Table 39. Global Anti-aging and Longevity Drugs Sales Volume by Application (2027-2032) & (K Units) Table 40. Global Anti-aging and Longevity Drugs Sales Volume Share by Application (2021-2026) Table 41. Global Anti-aging and Longevity Drugs Sales Volume Share by Application (2027-2032) Table 42. Global Anti-aging and Longevity Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global Anti-aging and Longevity Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 44. Global Anti-aging and Longevity Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 45. Global Anti-aging and Longevity Drugs Sales Value Share by Application (2021-2026) Table 46. Global Anti-aging and Longevity Drugs Sales Value Share by Application (2027-2032) Table 47. Global Anti-aging and Longevity Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 48. Global Anti-aging and Longevity Drugs Sales by Region (2021-2026) & (K Units) Table 49. Global Anti-aging and Longevity Drugs Sales Market Share by Region (2021-2026) Table 50. Global Anti-aging and Longevity Drugs Sales by Region (2027-2032) & (K Units) Table 51. Global Anti-aging and Longevity Drugs Sales Market Share by Region (2027-2032) Table 52. Global Anti-aging and Longevity Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Anti-aging and Longevity Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 54. Global Anti-aging and Longevity Drugs Sales Value Share by Region (2021-2026) Table 55. Global Anti-aging and Longevity Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 56. Global Anti-aging and Longevity Drugs Sales Value Share by Region (2027-2032) Table 57. Global Anti-aging and Longevity Drugs Market Average Price (US$/Unit) by Region (2021-2026) Table 58. Global Anti-aging and Longevity Drugs Market Average Price (US$/Unit) by Region (2027-2032) Table 59. Global Anti-aging and Longevity Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 60. Global Anti-aging and Longevity Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Anti-aging and Longevity Drugs Sales by Country (2021-2026) & (K Units) Table 62. Global Anti-aging and Longevity Drugs Sales Market Share by Country (2021-2026) Table 63. Global Anti-aging and Longevity Drugs Sales by Country (2027-2032) & (K Units) Table 64. Global Anti-aging and Longevity Drugs Sales Market Share by Country (2027-2032) Table 65. Global Anti-aging and Longevity Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 66. Global Anti-aging and Longevity Drugs Sales Value Market Share by Country (2021-2026) Table 67. Global Anti-aging and Longevity Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 68. Global Anti-aging and Longevity Drugs Sales Value Market Share by Country (2027-2032) Table 69. Centrum Company Information Table 70. Centrum Business Overview Table 71. Centrum Anti-aging and Longevity Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Centrum Anti-aging and Longevity Drugs Product Portfolio Table 73. Centrum Recent Development Table 74. GNC Company Information Table 75. GNC Business Overview Table 76. GNC Anti-aging and Longevity Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. GNC Anti-aging and Longevity Drugs Product Portfolio Table 78. GNC Recent Development Table 79. Herbalmax Company Information Table 80. Herbalmax Business Overview Table 81. Herbalmax Anti-aging and Longevity Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Herbalmax Anti-aging and Longevity Drugs Product Portfolio Table 83. Herbalmax Recent Development Table 84. HUM Nutrition Company Information Table 85. HUM Nutrition Business Overview Table 86. HUM Nutrition Anti-aging and Longevity Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. HUM Nutrition Anti-aging and Longevity Drugs Product Portfolio Table 88. HUM Nutrition Recent Development Table 89. MegaFood Company Information Table 90. MegaFood Business Overview Table 91. MegaFood Anti-aging and Longevity Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. MegaFood Anti-aging and Longevity Drugs Product Portfolio Table 93. MegaFood Recent Development Table 94. Natrol Company Information Table 95. Natrol Business Overview Table 96. Natrol Anti-aging and Longevity Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Natrol Anti-aging and Longevity Drugs Product Portfolio Table 98. Natrol Recent Development Table 99. Nature Made Company Information Table 100. Nature Made Business Overview Table 101. Nature Made Anti-aging and Longevity Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Nature Made Anti-aging and Longevity Drugs Product Portfolio Table 103. Nature Made Recent Development Table 104. Nature's Bounty Company Information Table 105. Nature's Bounty Business Overview Table 106. Nature's Bounty Anti-aging and Longevity Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Nature's Bounty Anti-aging and Longevity Drugs Product Portfolio Table 108. Nature's Bounty Recent Development Table 109. New Chapter Company Information Table 110. New Chapter Business Overview Table 111. New Chapter Anti-aging and Longevity Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. New Chapter Anti-aging and Longevity Drugs Product Portfolio Table 113. New Chapter Recent Development Table 114. Pure Encapsulations Company Information Table 115. Pure Encapsulations Business Overview Table 116. Pure Encapsulations Anti-aging and Longevity Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Pure Encapsulations Anti-aging and Longevity Drugs Product Portfolio Table 118. Pure Encapsulations Recent Development Table 119. The Vitamin Shoppe Company Information Table 120. The Vitamin Shoppe Business Overview Table 121. The Vitamin Shoppe Anti-aging and Longevity Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. The Vitamin Shoppe Anti-aging and Longevity Drugs Product Portfolio Table 123. The Vitamin Shoppe Recent Development Table 124. China Resources Double-Crane Pharmaceutical Co.,Ltd. Company Information Table 125. China Resources Double-Crane Pharmaceutical Co.,Ltd. Business Overview Table 126. China Resources Double-Crane Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. China Resources Double-Crane Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Product Portfolio Table 128. China Resources Double-Crane Pharmaceutical Co.,Ltd. Recent Development Table 129. GeneHarbor (Hong Kong) Biotechnologies Limited Company Information Table 130. GeneHarbor (Hong Kong) Biotechnologies Limited Business Overview Table 131. GeneHarbor (Hong Kong) Biotechnologies Limited Anti-aging and Longevity Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. GeneHarbor (Hong Kong) Biotechnologies Limited Anti-aging and Longevity Drugs Product Portfolio Table 133. GeneHarbor (Hong Kong) Biotechnologies Limited Recent Development Table 134. Xiamen Kingdomway Group Company Company Information Table 135. Xiamen Kingdomway Group Company Business Overview Table 136. Xiamen Kingdomway Group Company Anti-aging and Longevity Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Xiamen Kingdomway Group Company Anti-aging and Longevity Drugs Product Portfolio Table 138. Xiamen Kingdomway Group Company Recent Development Table 139. Shinkowa Company Information Table 140. Shinkowa Business Overview Table 141. Shinkowa Anti-aging and Longevity Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Shinkowa Anti-aging and Longevity Drugs Product Portfolio Table 143. Shinkowa Recent Development Table 144. Yaben Chemical Company Information Table 145. Yaben Chemical Business Overview Table 146. Yaben Chemical Anti-aging and Longevity Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Yaben Chemical Anti-aging and Longevity Drugs Product Portfolio Table 148. Yaben Chemical Recent Development Table 149. Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Company Information Table 150. Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Business Overview Table 151. Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Product Portfolio Table 153. Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Recent Development Table 154. Key Raw Materials Table 155. Raw Materials Key Suppliers Table 156. Anti-aging and Longevity Drugs Distributors List Table 157. Anti-aging and Longevity Drugs Customers List Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources Table 161. Primary Sources List of Figures Figure 1. Anti-aging and Longevity Drugs Product Image Figure 2. Global Anti-aging and Longevity Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-aging and Longevity Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Anti-aging and Longevity Drugs Sales (2021-2032) & (K Units) Figure 5. Global Anti-aging and Longevity Drugs Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Anti-aging and Longevity Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Resveratrol Image Figure 10. Coenzyme Q10 and Collagen Image Figure 11. Biotin Image Figure 12. Vitamins Image Figure 13. Nicotinamide Mononucleotide (NMN) Image Figure 14. Others Image Figure 15. Global Anti-aging and Longevity Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Anti-aging and Longevity Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global Anti-aging and Longevity Drugs Sales Volume Share by Type (2021-2032) Figure 18. Global Anti-aging and Longevity Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Anti-aging and Longevity Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Anti-aging and Longevity Drugs Sales Value Share by Type (2021-2032) Figure 21. Retail Pharmacies Image Figure 22. Online Pharmacies Image Figure 23. Hospitals Image Figure 24. Clinics Image Figure 25. Global Anti-aging and Longevity Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Anti-aging and Longevity Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 27. Global Anti-aging and Longevity Drugs Sales Volume Share by Application (2021-2032) Figure 28. Global Anti-aging and Longevity Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Anti-aging and Longevity Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 30. Global Anti-aging and Longevity Drugs Sales Value Share by Application (2021-2032) Figure 31. Global Anti-aging and Longevity Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 32. Global Anti-aging and Longevity Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 33. Global Anti-aging and Longevity Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 34. Global Anti-aging and Longevity Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 35. North America Anti-aging and Longevity Drugs Sales Value (2021-2032) & (US$ Million) Figure 36. North America Anti-aging and Longevity Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Europe Anti-aging and Longevity Drugs Sales Value (2021-2032) & (US$ Million) Figure 38. Europe Anti-aging and Longevity Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Asia-Pacific Anti-aging and Longevity Drugs Sales Value (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Anti-aging and Longevity Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 41. South America Anti-aging and Longevity Drugs Sales Value (2021-2032) & (US$ Million) Figure 42. South America Anti-aging and Longevity Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 43. Middle East & Africa Anti-aging and Longevity Drugs Sales Value (2021-2032) & (US$ Million) Figure 44. Middle East & Africa Anti-aging and Longevity Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 45. USA Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. USA Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. USA Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Canada Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Canada Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Canada Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Mexico Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Mexico Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Mexico Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Germany Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Germany Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Germany Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. France Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. France Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. France Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. U.K. Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. U.K. Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. U.K. Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Italy Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Italy Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Italy Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Spain Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Spain Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Spain Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Russia Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Russia Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Russia Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Netherlands Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Netherlands Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Netherlands Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Nordic Countries Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Nordic Countries Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Nordic Countries Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. China Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. China Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. China Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Japan Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Japan Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Japan Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. South Korea Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. South Korea Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. South Korea Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. India Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. India Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. India Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Australia Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Australia Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Australia Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Southeast Asia Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Southeast Asia Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Southeast Asia Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Brazil Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Brazil Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Brazil Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Argentina Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Argentina Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Argentina Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Chile Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Chile Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Chile Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Colombia Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Colombia Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Colombia Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Peru Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Peru Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Peru Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Saudi Arabia Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Israel Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Israel Arabia Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Israel Arabia Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. UAE Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. UAE Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. UAE Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Turkey Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Turkey Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Turkey Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Iran Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Iran Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Iran Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Egypt Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 127. Egypt Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 128. Egypt Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 129. Anti-aging and Longevity Drugs Value Chain Figure 130. Manufacturing Cost Structure Figure 131. Anti-aging and Longevity Drugs Sales Mode & Process Figure 132. Direct Comparison with Distribution Share Figure 133. Distributors Profiles Figure 134. Years Considered Figure 135. Research Process Figure 136. Key Executives Interviewed

Scope & coverage.

Types
  • Resveratrol
  • Coenzyme Q10 and Collagen
  • Biotin
  • Vitamins
  • Nicotinamide Mononucleotide (NMN)
  • Others
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospitals
  • Clinics
Companies covered
  • Centrum
  • GNC
  • Herbalmax
  • HUM Nutrition
  • MegaFood
  • Natrol
  • Nature Made
  • Nature's Bounty
  • New Chapter
  • Pure Encapsulations
  • The Vitamin Shoppe
  • China Resources Double-Crane Pharmaceutical Co.,Ltd.
  • GeneHarbor (Hong Kong) Biotechnologies Limited
  • Xiamen Kingdomway Group Company
  • Shinkowa
  • Yaben Chemical
  • Guangdong Zhongsheng Pharmaceutical Co.,Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Anti-aging and Longevity Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Anti-aging and Longevity Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Anti-aging and Longevity Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Anti-aging and Longevity Drugs Market Dynamics
  1. 2.1 Anti-aging and Longevity Drugs Industry Trends
  2. 2.2 Anti-aging and Longevity Drugs Industry Drivers
  3. 2.3 Anti-aging and Longevity Drugs Industry Opportunities and Challenges
  4. 2.4 Anti-aging and Longevity Drugs Industry Restraints
3 Anti-aging and Longevity Drugs Market by Company
  1. 3.1 Global Anti-aging and Longevity Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Anti-aging and Longevity Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Anti-aging and Longevity Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Anti-aging and Longevity Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Anti-aging and Longevity Drugs Company Ranking (2024-2026)
  6. 3.6 Global Anti-aging and Longevity Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Anti-aging and Longevity Drugs Company Product Type and Application
  8. 3.8 Global Anti-aging and Longevity Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Anti-aging and Longevity Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Anti-aging and Longevity Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Anti-aging and Longevity Drugs Market by Type
  1. 4.1 Anti-aging and Longevity Drugs Type Introduction
  2. 4.1.1 Resveratrol
  3. 4.1.2 Coenzyme Q10 and Collagen
  4. 4.1.3 Biotin
  5. 4.1.4 Vitamins
  6. 4.1.5 Nicotinamide Mononucleotide (NMN)
  7. 4.1.6 Others
  8. 4.2 Global Anti-aging and Longevity Drugs Sales Volume by Type
  9. 4.2.1 Global Anti-aging and Longevity Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Anti-aging and Longevity Drugs Sales Volume by Type (2021-2032)
  11. 4.2.3 Global Anti-aging and Longevity Drugs Sales Volume Share by Type (2021-2032)
  12. 4.3 Global Anti-aging and Longevity Drugs Sales Value by Type
  13. 4.3.1 Global Anti-aging and Longevity Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Anti-aging and Longevity Drugs Sales Value by Type (2021-2032)
  15. 4.3.3 Global Anti-aging and Longevity Drugs Sales Value Share by Type (2021-2032)
5 Anti-aging and Longevity Drugs Market by Application
  1. 5.1 Anti-aging and Longevity Drugs Application Introduction
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Hospitals
  5. 5.1.4 Clinics
  6. 5.2 Global Anti-aging and Longevity Drugs Sales Volume by Application
  7. 5.2.1 Global Anti-aging and Longevity Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Anti-aging and Longevity Drugs Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Anti-aging and Longevity Drugs Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Anti-aging and Longevity Drugs Sales Value by Application
  11. 5.3.1 Global Anti-aging and Longevity Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Anti-aging and Longevity Drugs Sales Value by Application (2021-2032)
  13. 5.3.3 Global Anti-aging and Longevity Drugs Sales Value Share by Application (2021-2032)
6 Anti-aging and Longevity Drugs Regional Sales and Value Analysis
  1. 6.1 Global Anti-aging and Longevity Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Anti-aging and Longevity Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Anti-aging and Longevity Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Anti-aging and Longevity Drugs Sales by Region (2027-2032)
  5. 6.3 Global Anti-aging and Longevity Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Anti-aging and Longevity Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Anti-aging and Longevity Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Anti-aging and Longevity Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Anti-aging and Longevity Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Anti-aging and Longevity Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Anti-aging and Longevity Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Anti-aging and Longevity Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Anti-aging and Longevity Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Anti-aging and Longevity Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Anti-aging and Longevity Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Anti-aging and Longevity Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Anti-aging and Longevity Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Anti-aging and Longevity Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Anti-aging and Longevity Drugs Sales Value Share by Country, 2025 VS 2032
7 Anti-aging and Longevity Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Anti-aging and Longevity Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Anti-aging and Longevity Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Anti-aging and Longevity Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Anti-aging and Longevity Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Anti-aging and Longevity Drugs Sales by Country (2027-2032)
  6. 7.4 Global Anti-aging and Longevity Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Anti-aging and Longevity Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Anti-aging and Longevity Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Anti-aging and Longevity Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Anti-aging and Longevity Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Anti-aging and Longevity Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Centrum
  2. 8.1.1 Centrum Company Information
  3. 8.1.2 Centrum Business Overview
  4. 8.1.3 Centrum Anti-aging and Longevity Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Centrum Anti-aging and Longevity Drugs Product Portfolio
  6. 8.1.5 Centrum Recent Developments
  7. 8.2 GNC
  8. 8.2.1 GNC Company Information
  9. 8.2.2 GNC Business Overview
  10. 8.2.3 GNC Anti-aging and Longevity Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 GNC Anti-aging and Longevity Drugs Product Portfolio
  12. 8.2.5 GNC Recent Developments
  13. 8.3 Herbalmax
  14. 8.3.1 Herbalmax Company Information
  15. 8.3.2 Herbalmax Business Overview
  16. 8.3.3 Herbalmax Anti-aging and Longevity Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Herbalmax Anti-aging and Longevity Drugs Product Portfolio
  18. 8.3.5 Herbalmax Recent Developments
  19. 8.4 HUM Nutrition
  20. 8.4.1 HUM Nutrition Company Information
  21. 8.4.2 HUM Nutrition Business Overview
  22. 8.4.3 HUM Nutrition Anti-aging and Longevity Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 HUM Nutrition Anti-aging and Longevity Drugs Product Portfolio
  24. 8.4.5 HUM Nutrition Recent Developments
  25. 8.5 MegaFood
  26. 8.5.1 MegaFood Company Information
  27. 8.5.2 MegaFood Business Overview
  28. 8.5.3 MegaFood Anti-aging and Longevity Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 MegaFood Anti-aging and Longevity Drugs Product Portfolio
  30. 8.5.5 MegaFood Recent Developments
  31. 8.6 Natrol
  32. 8.6.1 Natrol Company Information
  33. 8.6.2 Natrol Business Overview
  34. 8.6.3 Natrol Anti-aging and Longevity Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Natrol Anti-aging and Longevity Drugs Product Portfolio
  36. 8.6.5 Natrol Recent Developments
  37. 8.7 Nature Made
  38. 8.7.1 Nature Made Company Information
  39. 8.7.2 Nature Made Business Overview
  40. 8.7.3 Nature Made Anti-aging and Longevity Drugs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Nature Made Anti-aging and Longevity Drugs Product Portfolio
  42. 8.7.5 Nature Made Recent Developments
  43. 8.8 Nature's Bounty
  44. 8.8.1 Nature's Bounty Company Information
  45. 8.8.2 Nature's Bounty Business Overview
  46. 8.8.3 Nature's Bounty Anti-aging and Longevity Drugs Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Nature's Bounty Anti-aging and Longevity Drugs Product Portfolio
  48. 8.8.5 Nature's Bounty Recent Developments
  49. 8.9 New Chapter
  50. 8.9.1 New Chapter Company Information
  51. 8.9.2 New Chapter Business Overview
  52. 8.9.3 New Chapter Anti-aging and Longevity Drugs Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 New Chapter Anti-aging and Longevity Drugs Product Portfolio
  54. 8.9.5 New Chapter Recent Developments
  55. 8.10 Pure Encapsulations
  56. 8.10.1 Pure Encapsulations Company Information
  57. 8.10.2 Pure Encapsulations Business Overview
  58. 8.10.3 Pure Encapsulations Anti-aging and Longevity Drugs Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Pure Encapsulations Anti-aging and Longevity Drugs Product Portfolio
  60. 8.10.5 Pure Encapsulations Recent Developments
  61. 8.11 The Vitamin Shoppe
  62. 8.11.1 The Vitamin Shoppe Company Information
  63. 8.11.2 The Vitamin Shoppe Business Overview
  64. 8.11.3 The Vitamin Shoppe Anti-aging and Longevity Drugs Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 The Vitamin Shoppe Anti-aging and Longevity Drugs Product Portfolio
  66. 8.11.5 The Vitamin Shoppe Recent Developments
  67. 8.12 China Resources Double-Crane Pharmaceutical Co.,Ltd.
  68. 8.12.1 China Resources Double-Crane Pharmaceutical Co.,Ltd. Company Information
  69. 8.12.2 China Resources Double-Crane Pharmaceutical Co.,Ltd. Business Overview
  70. 8.12.3 China Resources Double-Crane Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 China Resources Double-Crane Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Product Portfolio
  72. 8.12.5 China Resources Double-Crane Pharmaceutical Co.,Ltd. Recent Developments
  73. 8.13 GeneHarbor (Hong Kong) Biotechnologies Limited
  74. 8.13.1 GeneHarbor (Hong Kong) Biotechnologies Limited Company Information
  75. 8.13.2 GeneHarbor (Hong Kong) Biotechnologies Limited Business Overview
  76. 8.13.3 GeneHarbor (Hong Kong) Biotechnologies Limited Anti-aging and Longevity Drugs Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 GeneHarbor (Hong Kong) Biotechnologies Limited Anti-aging and Longevity Drugs Product Portfolio
  78. 8.13.5 GeneHarbor (Hong Kong) Biotechnologies Limited Recent Developments
  79. 8.14 Xiamen Kingdomway Group Company
  80. 8.14.1 Xiamen Kingdomway Group Company Company Information
  81. 8.14.2 Xiamen Kingdomway Group Company Business Overview
  82. 8.14.3 Xiamen Kingdomway Group Company Anti-aging and Longevity Drugs Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Xiamen Kingdomway Group Company Anti-aging and Longevity Drugs Product Portfolio
  84. 8.14.5 Xiamen Kingdomway Group Company Recent Developments
  85. 8.15 Shinkowa
  86. 8.15.1 Shinkowa Company Information
  87. 8.15.2 Shinkowa Business Overview
  88. 8.15.3 Shinkowa Anti-aging and Longevity Drugs Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Shinkowa Anti-aging and Longevity Drugs Product Portfolio
  90. 8.15.5 Shinkowa Recent Developments
  91. 8.16 Yaben Chemical
  92. 8.16.1 Yaben Chemical Company Information
  93. 8.16.2 Yaben Chemical Business Overview
  94. 8.16.3 Yaben Chemical Anti-aging and Longevity Drugs Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Yaben Chemical Anti-aging and Longevity Drugs Product Portfolio
  96. 8.16.5 Yaben Chemical Recent Developments
  97. 8.17 Guangdong Zhongsheng Pharmaceutical Co.,Ltd.
  98. 8.17.1 Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Company Information
  99. 8.17.2 Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Business Overview
  100. 8.17.3 Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Product Portfolio
  102. 8.17.5 Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Anti-aging and Longevity Drugs Value Chain Analysis
  2. 9.1.1 Anti-aging and Longevity Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Anti-aging and Longevity Drugs Sales Mode & Process
  6. 9.2 Anti-aging and Longevity Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Anti-aging and Longevity Drugs Distributors
  9. 9.2.3 Anti-aging and Longevity Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst